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Thomas E. Starzl, and Rene Duquesnoy 
ORTHOTOPIC LIVER transplantation (OL T) is often 
accompanied by massive blood loss due to portal 
hypertension, difficult dissection as a result of previous 
abdominal surgery. and coagulation abnormalities. Major 
alterations of the coagulation factors such as prolonged 
prothrombin time (PT) and activated partial thromboplastin 
time (APTT). decreased fibrinogen levels and thrombocyto-
penia have already been documented in patients undergoing 
OLT. I•3 Moreover, problems like fibrinolysis and consump-
tion coagulopathy have been demonstrated to play an impor-
tant role in blood coagulation system alterations during such 
an operation;4.5 these factors often necessitate large quanti-
ties of blood products during OL T, despite recent 
adva nces. 2.6-8 
Packed red blood cells (RBC), fresh frozen plasma (FFP), 
platelets (PL T) and cryoprecipitate (CRY) represent the 
different blood fractions commonly transfused during OL T. 
The relation between massive blood use in 0 L T, morbidity9 
and mortalitylO.1I has already been described. 
We have investigated the role of HLA alloimmunization 
in intraoperative blood transfusion requirements during 
OL T. Alloimmunization can result from previous exposure 
to HLA antigens through transfusion, transplantation and 
pregnancy and is usually detected by serum screening for 
lymphocytotoxic antibodies. 
HLA plays a significant role in blood transfusions espe-
cially those involving platelets. It is well known that PL T 
express class I HLA antigens and specific alloimmunization 
to these antigens is a major cause of refractoriness in 
thrombocytopenic patients to platelet transfusions. 12·14 
Our results demonstrate that HLA alloimmunization has 
a major effect on blood transfusion requirements during 
aLT. Intraoperative blood use was significantly increased in 
alloimmunized liver transplant recipients. This retrospective 
study indicates that pre-transplant screening of liver candi-
dates is useful in estimating blood transfusion requirements 
duringOLT. 
PATIENTS AND METHODS 
Between March 1980 and December 1986, 1053 OL Ts were 
performed in the Departments of Surgery of the University of 
Pittsburgh and the Baylor Medical Center in Dallas. The case series 
includes first (821 ), second and third OLTs. 
Two groups of adult patients were selected from our liver 
transplant file on the basis of panel reactive antibody (PRA) 
of pre-transplant serum as determined by lymphocytotoxic-
ity testing with a panel of 45-60 HLA typed donors as 
previously described. 15 One group of highly alloimmunized 
patients (n = 25) had PRA values greater than 70% and the 
second group of nonsensitized patients (n = 26) had PRA 
values of 0%. Patients who had undergone major surgery 
immediately prior to transplantation and patients with intra-
operative bleeding due to technical reasons were excluded. 
Both groups of patients were randomly selected except for 
PRA. All cases were first transplants and there were no 
significant age, weight and pathology differences between 
the two groups (Table I). Heparin was never used pre-
and / or intraoperatively. Intraoperative blood replacement 
was determined by thromboelastrographic monitoring as 
previously described.2 Intraoperative infusion of RBC, PL T, 
FFP and CRY was retrospectively analyzed, in each group. 
Statistical analysis was done by Student's t and Mann 
Whitney U test. Data are shown in mean values ± standard 
error. 
RESULTS 
Highly sensitized patients (70% PRA group) received intra-
operatively 21.1 ± 3.7 units of RBC and 17.7 ± 3.2 units of 
PL T, significantly more than nonsensitized patients (0% 
PRA group) who received 9.8 ± 0.8 units of RBC and 7.5 ± 
1.5 units of PL T (RBC: p = 0_002; PLT: p = 0.003) (Fig. 1). 
In addition, transfusion of FFP and CRY was significantly 
higher in the 70% PRA group than in the 0% PRA group 
(FFP: 20.4 ± 4.2 vs 9.2 ± 6.0, p = 0.006; CRY: 8.3 ± 2.5 vs 
3.6 ± 1.2, p = 0.026) (Fig I). 
Despite the larger PL T substitution in the 70% PRA 
group, as shown in Figure 1, PL T counts dropped from 
106,826 ± 13,714/mm3 preoperatively to 71,043 ± 7,816/ 
mm3 postoperatively (p = 0.006). In contrast, the 0% PRA 
group had similar pre- (119,600 ± 18,688/mm3) and postop-
erative (114,000 ± 14,617/mm3) PLTcounts (p = 0.55). 
PT, APTT, hematocrit, and fibrinogen level showed no 
significant differences between both groups (data not 
shown). 
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Fig 1. Intraoperative transfusions of red blood cells, plate-
lets, fresh frozen plasma, and cryopreclpltates In 25 highly 
sensitized (70% PRA group) and 26 non-sensitized (0% PRA 
group) patients. 
DISCUSSION 
Management of bleeding represents one of the most 
important aspects of OL T. Often OL T candidates have 
severe coagulation disturbances and the frequent presence of 
portal hypertension makes surgical hemostasis exceedingly 
difficul t. 3,6 
In several other reports the number of RBC un tis was used 
as a variable to evaluate intraoperative bleeding.9- 11 In our 
previous series of 87 OL Ts, the range for RBC units was very 
large, from 3 to 251, with a median of 24 and a mean of 43 
units;11 consequently, many attempts have been made to 
prevent the causes of bleeding during OL T. In addition to the 
importance of meticulous care in checking and suturing each 
potential source of bleeding during the operation,3.6 in the 
last years many efforts have been made to develop devices 
and strategies to aid in managing intraoperative bleeding. 
The veno-venous by-pass equipped with heparin coated 
tubes, inhibiting clot formation without causing generalized 
heparinization, has been very effective in reducing portal and 
caval hypertension and consequently blood loss during the 
an hepatic phase. 16 The infra-red sapphire-headed coagulator 
has been effective in reducing bleeding from difficulty man-
aged sites.3 
Intraoperative monitoring by thrombelastography in the 
last four years has reduced blood infusion volume by 33% 
and increased blood coagulation stability without adding 
blood products.2 Also, the appropriate use of epsilon-amino-
caproic acid in patients undergoing OL T 17,18 is very effective 
in treating fibrinolysis and associated generalized oozing. 
Despite advances, bleeding problems are still one of the 
major concerns in OL T, During OL T a generalized oozing 
may develop from all the cut surfaces, a phenomenon not 
related to mechanical trauma. This lengthens hemostasis 
time and necessitates larger amounts of blood products. The 
quantity of blood used correlates negatively (p = 0.0005) 
with survival as demonstrated in our previous investiga-
tions, 10, II 
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Table 1. Patient Population In the Non-Alloimmunized Group 
(0% PRA) and in the Highly-Alloimmunized Group (70% PRA) 
Patient %PRA 70% PRA 
Population Group Group 
Age (years) 44.1 ± 8.9 44.3 ± 10.8 
Weight (Kg) 67.5 ± 16.2 63.1 ± 16.1 
Primary biliary cirrhosis 6 6 
Chronic active hepatitis 7 9 
Laennec's disease 6 3 
Fulminant hepatitis 2 1 
Antitrypsin deficiency 3 
Others 4 3 
In this study we present evidence suggesting that lympho-
cytotoxic antibodies in OL T patients are associated with 
increased intraoperative blood transfusion requirements. 
Highly sensitized patients with PRA values equal to or 
greater than 70% received greater quantities of RBC, PL T, 
CRY and FFP intraoperatively than did the 0% PRA 
patients. 
Lymphocytotoxic antibodies are generally specific for 
HLA antigens. HLA alloimmunization is a major cause of 
platelet refractoriness in thrombocytopenic patients requir-
ing transfusions. Such refractory patients respond poorly to 
random ABO compatible platelets. 14 Our data suggest that 
platelet transfusions are also less effective in correcting the 
bleeding problems of highly sensitized patients undergoing 
OL T, This is more apparent from our findings that although 
the 70% PRA patients received larger quantities of PLT, 
they had significantly lower PL T counts postoperatively. 
This lower PL T count might be due to the "innocent 
bystander" effect whereby the patient's own PL T become 
involved in the immune clearance of incompatible PLTY 
Thus, in certain alloimmunized patients, random PL T trans-
fusions would not only be ineffective, but might also worsen 
the bleeding problems during surgery. 
Our data also show a close correlation between the 
amounts of transfused PL T and RBC in the 70% PRA group, 
but not in the 0% PRA group. This can be explained by the 
possibility that PLT tranfusion in the 70% PRA is not 
effective in correcting intraoperative bleeding, leading to 
increased RBC substitution in the 70% PRA group. 
The decreased coagulation status in the 70% PRA patients 
is indicated by the different requirement for plasma replace-
ment and substitution with concentrated fractions of coagu-
lations factors. The 70% PRA group needed significantly 
higher substitution with FFP and CRY than the 0% PRA 
group. 
In conclusion, our findings suggest that routine screening 
for HLA alloimmunization should be done in every OL T 
candidate as well as in all patients undergoing major surgical 
treatments who may require intraoperative PL T transfu-
sions. Highly sensitized patients are at risk of developing 
refractoriness to intraoperative PL T transfusions with subse-
quent uncontrollable bleeding. These patients might benefit 
from transfusions of histocompatible PL T to achieve suffi-
cient hemostasis. 
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